SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001012975-06-000019
Filing Date
2006-01-20
Accepted
2006-01-20 18:48:05
Documents
1
Period of Report
2006-01-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 6420
  Complete submission text file 0001012975-06-000019.txt   8737
Mailing Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
Solexa, Inc. (Issuer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address
Business Address 222 BERKELEY STREET SUITE 1650 BOSTON MA 02116 6173577474
OXFORD BIOSCIENCE PARTNERS IV LP (Reporting) CIK: 0001140484 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-22570 | Film No.: 06541818

Mailing Address
Business Address 31 ST JAMES AVENUE SUITE 905 BOSTON MA 02116 617-357-7474
MRNA FUND II LP (Reporting) CIK: 0001161302 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22570 | Film No.: 06541817